We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Rapid Method Developed to Identify Bacteria in Blood Samples

By LabMedica International staff writers
Posted on 23 Feb 2017
In clinical diagnostics and pathogen detection, profiling of complex samples for low-level genotypes represents a significant challenge. More...
Advances in speed, sensitivity, and extent of multiplexing of molecular pathogen detection assays are needed to improve patient care.

A desktop diagnosis tool has been developed that detects the presence of harmful bacteria in a blood sample in a matter of hours instead of days. The tool was made possible by a combination of proprietary chemistry, innovative electrical engineering and high-end imaging and analysis techniques powered by machine learning.

Bioengineers at the University of California San Diego extracted and purified blood from a clinical sample known to be negative for bacteria. Approximately 2,000 genomes of Listeria monocytogenes were added to the purified blood extraction. The maximum amount of the blood and bacterial DNA mixture (8.63 μL) was added to the polymerase chain reaction (PCR) master mix. The DNA was then placed on a digital chip that allowed each piece to independently multiply in its own small reaction. For the process to work at such small scales, each well containing DNA in the chip was only 20 pL in volume.

An MJ Research PTC-200 Thermal Cycler was used for endpoint amplification. The engineers imaged the melting process with the high-throughput microscope and fluorescent imaging was accomplished using a Nikon Eclipse Ti platform and they were able to capture the bacteria's melting curves. They then analyzed the curves with a machine-learning algorithm they developed. In previous work, the algorithm was trained on 37 different types of bacteria undergoing different reactions in different conditions. The scientists showed that it was able to identify bacteria strains with 99% and by contrast, the error rate for traditional methods can be up to 22.6%.

The team concluded that the resulting bacteria-specific melt curves are identified by Support Vector Machine learning, and individual pathogen loads are quantified. The platform reduces reaction volumes by 99.995% and achieves a greater than 200-fold increase in dynamic range of detection compared to traditional PCR high-resolution melting (HRM) approaches. The study was published on February 8, 2017, in the journal Scientific Reports.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Thyroid Test
Anti-Thyroid EIA Test
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.